Keywords: BCC, basal cell carcinoma; CBD, cannabidiol; FDA, US Food and Drug Administration; MM, medical marijuana; THC, tetrahydrocannabinol; basal cell carcinoma; mS, multiple sclerosis; medical marijuana; muscle cramps; vismodegib.